Does HYALURONIDASE Cause Maternal exposure timing unspecified? 64 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 64 reports of Maternal exposure timing unspecified have been filed in association with HYALURONIDASE (Phesgo). This represents 5.8% of all adverse event reports for HYALURONIDASE.
64
Reports of Maternal exposure timing unspecified with HYALURONIDASE
5.8%
of all HYALURONIDASE reports
61
Deaths
64
Hospitalizations
How Dangerous Is Maternal exposure timing unspecified From HYALURONIDASE?
Of the 64 reports, 61 (95.3%) resulted in death, 64 (100.0%) required hospitalization, and 64 (100.0%) were considered life-threatening.
Is Maternal exposure timing unspecified Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for HYALURONIDASE. However, 64 reports have been filed with the FAERS database.
What Other Side Effects Does HYALURONIDASE Cause?
Fatigue (375)
Alopecia (358)
Abdominal discomfort (355)
Arthralgia (349)
Diarrhoea (330)
Headache (328)
Hypertension (325)
Blood cholesterol increased (320)
Arthropathy (318)
Off label use (315)
What Other Drugs Cause Maternal exposure timing unspecified?
RITUXIMAB (402)
METHOTREXATE (350)
ADALIMUMAB (343)
DICLOFENAC (331)
TOCILIZUMAB (327)
HYDROXYCHLOROQUINE (309)
FOLIC ACID (304)
INFLIXIMAB (303)
LEFLUNOMIDE (302)
SECUKINUMAB (301)
Which HYALURONIDASE Alternatives Have Lower Maternal exposure timing unspecified Risk?
HYALURONIDASE vs HYALURONIDASE-OCSQ\OCRELIZUMAB
HYALURONIDASE vs HYALURONIDASE \RITUXIMAB
HYALURONIDASE vs HYALURONIDASE-ZZXF\PERTUZUMAB\TRASTUZUMAB
HYALURONIDASE vs HYDRALAZINE
HYALURONIDASE vs HYDRALAZINE\ISOSORBIDE DINITRATE